JP2958835B2 - Method for producing 4- (1-carboxyalkyl) azetidin-2-one derivative - Google Patents

Method for producing 4- (1-carboxyalkyl) azetidin-2-one derivative

Info

Publication number
JP2958835B2
JP2958835B2 JP3338673A JP33867391A JP2958835B2 JP 2958835 B2 JP2958835 B2 JP 2958835B2 JP 3338673 A JP3338673 A JP 3338673A JP 33867391 A JP33867391 A JP 33867391A JP 2958835 B2 JP2958835 B2 JP 2958835B2
Authority
JP
Japan
Prior art keywords
group
derivative
mmol
compound
azetidin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP3338673A
Other languages
Japanese (ja)
Other versions
JPH05170733A (en
Inventor
孝志 三浦
俊幸 村山
昭文 吉田
東洋彦 小林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takasago International Corp
Original Assignee
Takasago International Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takasago International Corp filed Critical Takasago International Corp
Priority to JP3338673A priority Critical patent/JP2958835B2/en
Priority to DE69231883T priority patent/DE69231883T2/en
Priority to EP92310901A priority patent/EP0546742B1/en
Priority to US07/987,779 priority patent/US5371214A/en
Publication of JPH05170733A publication Critical patent/JPH05170733A/en
Priority to US08/277,319 priority patent/US5574152A/en
Application granted granted Critical
Publication of JP2958835B2 publication Critical patent/JP2958835B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、種々の1β−アルキル
カルバペネム系抗菌剤の合成中間体として有用な4−
(1−カルボキシアルキル)アゼチジン−2−オン誘導
体の製造法に関する。
BACKGROUND OF THE INVENTION The present invention relates to 4- (1-alkylcarbapenem) antibacterial agents useful as synthetic intermediates.
The present invention relates to a method for producing a (1-carboxyalkyl) azetidin-2-one derivative.

【0002】[0002]

【従来の技術及び発明が解決しようとする課題】カルバ
ペネム系抗菌剤は、グラム陽性菌から緑膿菌を含むグラ
ム陰性菌にわたる広範囲の細菌に対して強い抗菌力を有
する優れた抗菌剤であるため、近年、活発に開発がなさ
れている。式(3)
2. Description of the Related Art Carbapenem antibacterial agents are excellent antibacterial agents having strong antibacterial activity against a wide range of bacteria from Gram-positive bacteria to Gram-negative bacteria including Pseudomonas aeruginosa. In recent years, it has been actively developed. Equation (3)

【0003】[0003]

【化3】 Embedded image

【0004】で表されるチエナマイシンなどカルバペネ
ム骨格の1位に置換基を有していないカルバペネム類は
高濃度では化学的に不安定であり、しかも腎デヒドロペ
プチダーゼにより容易に代謝されてしまうという欠点を
有するが、1位にβ−配置のアルキル基を導入すると安
定性が増し、腎デヒドロペプチダーゼ阻害剤を配合する
ことなく単独使用が可能となる。このため、現在では1
β−アルキルカルバペネム系抗菌剤の開発に力が入れら
れており、その合成中間体となる一般式(2β)
Carbapenems which do not have a substituent at the 1-position of the carbapenem skeleton, such as thienamycin, are chemically unstable at high concentrations and are easily metabolized by renal dehydropeptidase. However, the introduction of a β-configuration alkyl group at the 1-position increases the stability and enables the use alone without blending a renal dehydropeptidase inhibitor. For this reason, 1
The development of β-alkylcarbapenem antibacterials has been focused on, and the synthetic formula (2β)

【0005】[0005]

【化4】 Embedded image

【0006】(式中、R3は低級アルキル基を示し、R4
は水素原子又は水酸基の保護基を示す)で表される4−
〔(R)−1−カルボキシアルキル〕アゼチジン−2−
オン誘導体の合成法の開発も盛んに行われている。
[0006] (wherein, R 3 represents a lower alkyl group, R 4
Represents a protecting group for a hydrogen atom or a hydroxyl group).
[(R) -1-carboxyalkyl] azetidine-2-
Development of a method for synthesizing on derivatives is also actively pursued.

【0007】この化合物(2β)の合成法としては、多
くの報告がなされているが、特に一般式(4)
Although many reports have been made on the method of synthesizing this compound (2β), the compound of the general formula (4)

【0008】[0008]

【化5】 Embedded image

【0009】(式中、Rは前記と同じ意味を示し、A
cはアセチル基を示す)で表される4−アセトキシアゼ
チジン−2−オン誘導体の4位を、種々の求核剤により
アルキル化することにより、側鎖を導入する方法が最も
期待されており、プロピオン酸エステルエノラートによ
るアルキル化〔C.U.Kimら;Tetrahedr
on Lett.,28(5)507−510(198
7)、T.Chibaら;Chem.Lett.,13
43−1346(1985)、T.Shibataら;
Tetrahedron Lett.,26(39)4
739−4742(1985)〕、プロピオン酸イミド
のエノラートによるアルキル化〔Y.Nagaoら;
J.Am.Chem.Soc.,108,4673−4
675(1986)、長尾善光;化学,42(3)19
0−196(1987)、L.M.Fuentesら;
J.Am.Chem.Soc.,108,4675−4
676(1986)、R.Dezielら;Tetra
hedron Lett.,27(47)5687−5
690(1986)、Y.Itoら;Tetrahed
ron Lett.,28(52)6625−6628
(1987)、プロピオン酸チオールエステルエノラー
トによるアルキル化〔M.Endo;Can.J.Ch
em.,65,2140−2145(1987)、C.
U.Kimら;Tetrahedron Lett.,
28(5)507−510(1987)、A.Mart
elら;Can.J.Chem.,66,1537−1
539(1988)〕などが報告されている。化合物
(2β)のその他の合成法としては、例えば化合物
(5)
(Wherein, R 4 has the same meaning as described above;
c represents an acetyl group), and the method of introducing a side chain by alkylating the 4-position of the 4-acetoxyazetidin-2-one derivative represented by the formula (1) with various nucleophiles is most expected. , Alkylation with propionate enolate [C. U. Kim et al .; Tetrahedr.
on Lett. , 28 (5) 507-510 (198
7), T. Chiba et al .; Chem. Lett. , 13
43-1346 (1985); Shibata et al .;
Tetrahedron Lett. , 26 (39) 4
739-4742 (1985)], alkylation of propionimide with an enolate [Y. Nagao et al .;
J. Am. Chem. Soc. , 108 , 4673-4
675 (1986), Nagamitsu Yoshimitsu; Chemistry, 42 (3) 19
0-196 (1987); M. Fuentes et al .;
J. Am. Chem. Soc. , 108 , 4675-4
676 (1986); Deziel et al; Tetra
hedron Lett. , 27 (47) 5687-5
690 (1986); Ito et al .; Tetrahed
ron Lett. , 28 (52) 6625-6628
(1987), alkylation with propionate thiol ester enolate [M. Endo; Can. J. Ch
em. , 65 , 2140-2145 (1987), C.I.
U. Kim et al; Tetrahedron Lett. ,
28 (5) 507-510 (1987); Mart
el et al; Can. J. Chem. , 66 , 1537-1
539 (1988)]. Other methods for synthesizing compound (2β) include, for example, compound (5)

【0010】[0010]

【化6】 Embedded image

【0011】(式中、R4は前記と同じ意味を示す)を
リチウムジイソプロピルアミドによりアルキル化する方
法〔D.H.Shihら;Heterocycles,
21(1)29−40(1984)、化合物(6)
(Wherein R 4 has the same meaning as described above) with lithium diisopropylamide [D. H. Shih et al .; Heterocycles,
21 (1) 29-40 (1984), compound (6)

【0012】[0012]

【化7】 Embedded image

【0013】(式中、R4は前記と同じ意味を示し、R5
は水素原子又はアミノ基の保護基を示し、R6はアルキ
ル基、カルボキシ基又はアルコキシカルボニル基を示
す)のエキソメチレン基を接触還元又は特定の触媒によ
り不斉還元する方法〔特開昭58−26887号公報、
C.U.Kimら;Tetrahedron Let
t.,28(5)507−510(1987)、T.O
htaら;J.Org.Chem.,52,3176−
3178(1987)、T.Iimoriら;Tetr
ahedron Lett.,27(19)2149−
2152(1986)〕などがあり、総説〔伊藤芳雄
ら;有機合成化学、47(7)606−618(198
9)〕に報告されている。
[0013] (wherein, R 4 are as defined above, R 5
Represents a protecting group for a hydrogen atom or an amino group, and R 6 represents an alkyl group, a carboxy group or an alkoxycarbonyl group). No. 26887,
C. U. Kim et al; Tetrahedron Let
t. , 28 (5) 507-510 (1987); O
hta et al .; Org. Chem. , 52 , 3176
3178 (1987); Iimori et al .; Tetr
ahedron Lett. , 27 (19) 2149-
2152 (1986)], and a review article [Yoshio Ito et al .; Synthetic Organic Chemistry, 47 (7) 606-618 (198).
9)].

【0014】これらの方法で得られる化合物(2β)
は、ほとんどの場合、その立体異性体である化合物(2
α)
Compound (2β) obtained by these methods
Is most often the stereoisomer of the compound (2
α)

【0015】[0015]

【化8】 Embedded image

【0016】(式中、R3及びR4は前記と同じ意味を示
す)と特定の割合で混合した化合物(2)
(Wherein R 3 and R 4 have the same meanings as described above) and a compound (2) mixed at a specific ratio

【0017】[0017]

【化9】 Embedded image

【0018】(式中、R3及びR4は前記と同じ意味を示
す)として得られるが、このα−配置のアルキル基を有
する化合物(2α)は、例えば、D.H.Shihら;
Heterocycles,21(1)29−40(1
984)に記載されている方法により異性化を行えば、
目的とするβ−配置のアルキル基を有する化合物(2
β)とすることができる。
(Wherein R 3 and R 4 have the same meanings as described above). The compound (2α) having an alkyl group in α-configuration can be obtained, for example, from D.I. H. Shih et al .;
Heterocycles, 21 (1) 29-40 (1
If isomerization is carried out by the method described in No. 984),
Compounds having the desired alkyl group of β-configuration (2
β).

【0019】しかしながら、前記した化合物(2)及び
化合物(2β)の合成法は、特殊で高価な試薬を用いた
り、反応温度が極めて低かったり、高価な金属や毒性の
ある金属を触媒として使用するなど、大量に合成するの
に適した方法ではなく、実際に工業的規模では製造され
ていないのが現状であった。
However, the above-mentioned methods for synthesizing the compound (2) and the compound (2β) use special and expensive reagents, have extremely low reaction temperatures, or use expensive metals or toxic metals as catalysts. For example, it is not a method suitable for mass synthesis, and is not actually manufactured on an industrial scale.

【0020】従って、化合物(2)、特に、1β−アル
キルカルバペネム系抗菌剤の合成中間体としてより利用
価値の高い、β−配置のアルキル基を有する化合物(2
β)を効率よく製造する方法の開発が望まれていた。
Accordingly, compound (2), particularly compound (2) having a β-configuration alkyl group, which is more useful as a synthetic intermediate for 1β-alkylcarbapenem-based antibacterial agents
Development of a method for efficiently producing β) has been desired.

【0021】[0021]

【課題を解決するための手段】かかる実情において、本
発明者らは鋭意研究を行った結果、アゼチジン−2−オ
ン骨格の4位にマロン酸誘導体が結合した4−(1,1
−ジアルコキシカルボニルアルキル)アゼチジン−2−
オン誘導体を原料として用い、これを脱エステル及び脱
炭酸せしめ、アミノ基の保護基が存在する場合には脱保
護せしめれば、4−(1−カルボキシアルキル)アゼチ
ジン−2−オン誘導体を効率よく製造することができる
ことを見出し、本発明を完成した。
Under these circumstances, the present inventors have conducted intensive studies, and as a result, have found that a malonic acid derivative is bonded to the 4-position of the azetidin-2-one skeleton.
-Dialkoxycarbonylalkyl) azetidine-2-
The 4- (1-carboxyalkyl) azetidin-2-one derivative can be efficiently obtained by using an on derivative as a raw material, de-esterifying and de-carboxylating it, and deprotecting if an amino-protecting group is present. They found that they could be manufactured and completed the present invention.

【0022】すなわち、本発明は、一般式(1)That is, the present invention provides a compound represented by the general formula (1):

【0023】[0023]

【化10】 Embedded image

【0024】(式中、R1及びR2は同一又は異なって、
それぞれアルキル基、アルケニル基又はアラルキル基を
示し、R3は低級アルキル基を示し、R4は水素原子又は
水酸基の保護基を示し、R5は水素原子又はアミノ基の
保護基を示す)で表される4−(1,1−ジアルコキシ
カルボニルアルキル)アゼチジン−2−オン誘導体を脱
エステル及び脱炭酸せしめ、アミノ基の保護基が存在す
る場合には脱保護せしめることを特徴とする一般式
(2)
(Wherein R 1 and R 2 are the same or different,
Each represents an alkyl group, an alkenyl group or an aralkyl group; R 3 represents a lower alkyl group; R 4 represents a hydrogen atom or a hydroxyl protecting group; and R 5 represents a hydrogen atom or an amino group protecting group). A 4- (1,1-dialkoxycarbonylalkyl) azetidin-2-one derivative to be subjected to deesterification and decarboxylation and, if an amino-protecting group is present, to deprotection. 2)

【0025】[0025]

【化11】 Embedded image

【0026】(式中、R3及びR4は前記と同じ意味を示
す)で表される4−(1−カルボキシアルキル)アゼチ
ジン−2−オン誘導体の製造法を提供するものである。
(Wherein R 3 and R 4 have the same meanings as described above). A method for producing a 4- (1-carboxyalkyl) azetidin-2-one derivative represented by the formula:

【0027】本発明において、原料として用いられる4
−(1,1−ジアルコキシカルボニルアルキル)アゼチ
ジン−2−オン誘導体は前記一般式(1)で表されるも
のであり、式中、R1及びR2で示されるアルキル基とし
ては、例えばメチル基、エチル基、n−プロピル基、イ
ソプロピル基、n−ブチル基、tert−ブチル基のよ
うな直鎖又は分岐鎖のアルキル基;シクロペンチル基、
シクロヘキシル基、メンチル基、フェンチル基、ボルニ
ル基のような単環又は多環のアルキル基が挙げられ、ア
ルケニル基としては、例えばビニル基、アリル基、2−
ブテニル基、2−メチル−2−プロペニル基のような直
鎖又は分岐鎖のアルケニル基が挙げられ、アラルキル基
としては、例えばベンジル基、ベンズヒドリル基等が挙
げられる。また、R3で示される低級アルキル基として
は、例えばメチル基、エチル基、n−プロピル基等が挙
げられ、R4で示される水酸基の保護基としては、例え
ばトリメチルシリル基、tert−ブチルジメチルシリ
ル基のような三置換シリル基;アセチル基のようなアシ
ル基;ベンジル基のようなアラルキル基等が挙げられ、
5で示されるアミノ基の保護基としては、例えばトリ
メチルシリル基、トリエチルシリル基、tert−ブチ
ルジメチルシリル基、メチルジフェニルシリル基のよう
な三置換シリル基;ベンジル基、p−メトキシベンジル
基、p−tert−ブチルベンジル基、3,4−ジメチ
ルベンジル基、フェネチル基、ベンズヒドリル基のよう
な芳香環上の置換基を有していてもよいアラルキル基;
テトラヒドロピラニル基、メトキシメチル基のようなア
ルコキシアルキル基等が挙げられる。
In the present invention, 4
The-(1,1-dialkoxycarbonylalkyl) azetidin-2-one derivative is represented by the general formula (1). In the formula, examples of the alkyl group represented by R 1 and R 2 include methyl A linear or branched alkyl group such as a group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group, and a tert-butyl group; a cyclopentyl group;
Monocyclic or polycyclic alkyl groups such as a cyclohexyl group, a mentyl group, a fentyl group, and a bornyl group are exemplified. Examples of the alkenyl group include a vinyl group, an allyl group,
A straight-chain or branched-chain alkenyl group such as a butenyl group and a 2-methyl-2-propenyl group can be mentioned, and examples of the aralkyl group include a benzyl group and a benzhydryl group. Examples of the lower alkyl group represented by R 3 include a methyl group, an ethyl group, and an n-propyl group. Examples of the protecting group for the hydroxyl group represented by R 4 include a trimethylsilyl group and a tert-butyldimethylsilyl group. A trisubstituted silyl group such as a group; an acyl group such as an acetyl group; an aralkyl group such as a benzyl group;
Examples of the protecting group for the amino group represented by R 5 include trisubstituted silyl groups such as trimethylsilyl group, triethylsilyl group, tert-butyldimethylsilyl group and methyldiphenylsilyl group; benzyl group, p-methoxybenzyl group, An aralkyl group which may have a substituent on an aromatic ring such as -tert-butylbenzyl group, 3,4-dimethylbenzyl group, phenethyl group, benzhydryl group;
Examples thereof include an alkoxyalkyl group such as a tetrahydropyranyl group and a methoxymethyl group.

【0028】これらの原料化合物(1)は、一般式
(1)においてR5が水素原子である場合(以下、「ア
ゼチジン−2−オン誘導体(1a)」と記載する)は、
例えばR.Joyeauらの方法〔J.Chem.So
c.,Perkin Trans.I,1899−19
07(1987)、Tetrahedron Let
t.,30(3)337−340(1989)〕に準
じ、下記式に従って4−アセトキシアゼチジン−2−オ
ン誘導体(4)に、マロン酸誘導体(7)を反応させる
ことにより製造される。
When R 5 is a hydrogen atom in the general formula (1) (hereinafter referred to as “azetidin-2-one derivative (1a)”),
For example, R. Joyeau et al. [J. Chem. So
c. , Perkin Trans. I, 1899-19
07 (1987), Tetrahedron Let
t. , 30 (3) 337-340 (1989)] and a malonic acid derivative (7) is reacted with a 4-acetoxyazetidin-2-one derivative (4) according to the following formula.

【0029】[0029]

【化12】 Embedded image

【0030】(式中、R1、R2、R3、R4及びAcは前
記と同じ意味を示す)
Wherein R 1 , R 2 , R 3 , R 4 and Ac have the same meaning as described above.

【0031】すなわち、金属カリウム、金属ナトリウ
ム、金属リチウムのようなアルカリ金属;水素化ナトリ
ウムのようなアルカリ金属水素化物;ブチルリチウムの
ようなアルカリ金属アルキル化物;カリウム−tert
−ブチラート、ナトリウムエチラート、ナトリウムメチ
ラートのようなアルカリ金属アルコキシド;水酸化カリ
ウム、水酸化ナトリウムのようなアルカリ金属水酸化
物;炭酸カリウムのようなアルカリ金属炭酸塩等で活性
化したマロン酸誘導体(7)溶液に、4−アセトキシア
ゼチジン−2−オン誘導体(4)を加え、−60〜40
℃、特に好ましくは室温で0.5〜15時間反応させる
ことにより製造される。ここで用いられる溶媒として
は、例えば水;メタノール、エタノールのようなアルコ
ール類;ジエチルエーテル、ジオキサン、テトラヒドロ
フランのようなエーテル類;アセトン;ジメチルホルム
アミド;あるいは水とこれらの有機溶媒との混合溶媒等
が挙げられるが、特に好ましくはテトラヒドロフランが
用いられる。反応化合物の比率は、4−アセトキシアゼ
チジン−2−オン誘導体(4)1モルに対し、マロン酸
誘導体(7)約1〜1.3モルとするのがよい。得られ
た4−(1,1−ジアルコキシカルボニルアルキル)ア
ゼチジン−2−オン誘導体(1a)は、通常の方法によ
り抽出、洗浄、脱水等をした後、再結晶、カラムクロマ
トグラフィー等により精製することができる。
Alkali metal such as potassium metal, sodium metal and lithium metal; alkali metal hydride such as sodium hydride; alkali metal alkylide such as butyl lithium; potassium-tert
Alkali metal alkoxides such as butyrate, sodium ethylate and sodium methylate; alkali metal hydroxides such as potassium hydroxide and sodium hydroxide; malonic acid derivatives activated with alkali metal carbonates such as potassium carbonate (7) A 4-acetoxyazetidin-2-one derivative (4) is added to the solution, and
C., particularly preferably at room temperature for 0.5 to 15 hours. Examples of the solvent used here include water; alcohols such as methanol and ethanol; ethers such as diethyl ether, dioxane and tetrahydrofuran; acetone; dimethylformamide; or a mixed solvent of water and these organic solvents. Among them, tetrahydrofuran is particularly preferably used. The ratio of the reaction compound is preferably about 1 to 1.3 mol of the malonic acid derivative (7) per 1 mol of the 4-acetoxyazetidin-2-one derivative (4). The obtained 4- (1,1-dialkoxycarbonylalkyl) azetidin-2-one derivative (1a) is subjected to extraction, washing, dehydration, etc. by a usual method, and then purified by recrystallization, column chromatography or the like. be able to.

【0032】一般式(1)においてR5がアミノ基の保
護基である場合(以下、「アゼチジン−2−オン誘導体
(1b)」と記載する)は、前記した方法でR5が水素
原子であるアゼチジン−2−オン誘導体(1a)を得た
後、通常の方法によりアミノ基の保護基を導入すること
により製造される。
In the general formula (1), when R 5 is a protecting group for an amino group (hereinafter referred to as “azetidin-2-one derivative (1b)”), R 5 is a hydrogen atom by the above-mentioned method. After obtaining a certain azetidin-2-one derivative (1a), it is produced by introducing an amino-protecting group by an ordinary method.

【0033】本発明においては、このようにして得られ
る化合物(1)を、通常の方法により脱エステル及び脱
炭酸することにより、目的とする4−(1−カルボキシ
アルキル)アゼチジン−2−オン誘導体(2)を得るこ
とができる。
In the present invention, the desired 4- (1-carboxyalkyl) azetidin-2-one derivative is obtained by subjecting the thus obtained compound (1) to deesterification and decarboxylation by a conventional method. (2) can be obtained.

【0034】[0034]

【化13】 Embedded image

【0035】(式中、R1、R2、R3、R4及びR5は前
記と同じ意味を示す)
(Wherein R 1 , R 2 , R 3 , R 4 and R 5 have the same meaning as described above)

【0036】この脱エステル及び脱炭酸反応は、例えば
通常の加水分解及び加熱反応によって行うことができ
る。すなわち、化合物(1)を水酸化ナトリウム、水酸
化カリウム、水酸化リチウム等の塩基の存在下で加水分
解し、次いで80〜120℃に加熱することにより脱炭
酸を行えばよい。また、RびRがアラルキル基であ
る場合には、アミンの存在下パラジウム炭素を用いた水
素添加によって脱エステル化を行うこともできる。
This deesterification and decarboxylation reaction can be carried out, for example, by ordinary hydrolysis and heating reactions. That is, the compound (1) may be hydrolyzed in the presence of a base such as sodium hydroxide, potassium hydroxide or lithium hydroxide, and then decarbonated by heating to 80 to 120 ° C. When R 1 and R 2 are aralkyl groups, deesterification can also be performed by hydrogenation using palladium carbon in the presence of an amine.

【0037】R及びRが2−アルケニル基である化
合物(1)を原料として用いる場合には、当該脱エステ
ル及び脱炭酸反応は、前述の方法により行うこともでき
るが、例えばJ.Tsujiらの方法〔Tetrahe
dron Lett.,20(7)613−616(1
979)〕を応用して、化合物(1)にパラジウム化合
物の存在下、ギ酸又はギ酸のアミン塩を反応させること
により行えば、脱エステル及び脱炭酸を一段階で行うこ
とができ、好ましい。ここで用いられるパラジウム化合
物は、活性種である0価のパラジウムを反応系内で生成
させ得るものであればよく、具体的には酢酸パラジウ
ム、塩化パラジウム、パラジウムアセチルアセトナート
のような2価のパラジウム化合物;トリベンジリデンジ
パラジウム、テトラキストリフェニルホスフィンパラジ
ウムのような0価のパラジウム化合物等が挙げられ、更
に、配位子として、トリエチルホスフィン、トリブチル
ホスフィンのようなトリアルキルホスフィン;トリフェ
ニルホスフィン、トリトリルホスフィンのようなトリア
リールホスフィン等を混在させることにより、反応系中
で錯体を形成し、触媒として作用して反応を進行せしめ
る。この反応は、例えば1,4−ジオキサン、テトラヒ
ドロフランのようなエーテル類;トルエン;ベンゼン等
の溶媒を用いて、1〜5時間加熱還流せしめることによ
り行われる。反応化合物の比率は、アゼチジン−2−オ
ン(1)1モルに対し、パラジウム化合物約0.01〜
0.1モル、ギ酸又はギ酸のアミン塩約3〜15モルと
するのがよい。
When the compound (1) in which R 1 and R 2 are 2-alkenyl groups is used as a raw material, the deesterification and decarboxylation can be carried out by the above-mentioned methods. The method of Tsuji et al. [Tetrahe
drone Lett. , 20 (7) 613-616 (1
979)], the esterification and decarboxylation can be carried out in one step, preferably by reacting the compound (1) with formic acid or an amine salt of formic acid in the presence of a palladium compound. The palladium compound used here may be any as long as it can generate zero-valent palladium as an active species in the reaction system, and specifically, a divalent compound such as palladium acetate, palladium chloride, or palladium acetylacetonate. Palladium compounds; zero-valent palladium compounds such as tribenzylidene dipalladium and tetrakistriphenylphosphine palladium; and the like. Further, as ligands, trialkylphosphines such as triethylphosphine and tributylphosphine; triphenylphosphine and triphenylphosphine. When a triarylphosphine such as tolylphosphine is mixed, a complex is formed in the reaction system and acts as a catalyst to cause the reaction to proceed. This reaction is carried out by heating and refluxing for 1 to 5 hours using a solvent such as ethers such as 1,4-dioxane and tetrahydrofuran; toluene; benzene. The ratio of the reaction compound is about 0.01 to 1 mol of the palladium compound per 1 mol of azetidin-2-one (1).
It is preferably 0.1 mol, formic acid or about 3 to 15 mol of formic acid amine salt.

【0038】原料化合物が、一般式(1)においてR
が水素原子であるアゼチジン−2−オン誘導体(1a)
である場合には、これらの脱エステル・脱炭酸反応によ
り得られる化合物(2)は、α−アルキル体(2α)が
選択的に得られる。最終目的物であるカルバペネム骨格
の1位のアルキル基の立体配置はβ−配置であるが、得
られたα−アルキル体(2α)は前記した公知の方法に
より異性化を行い、β−アルキル体(2β)とすること
ができる。
The starting compound is, in the general formula (1) R 5
Is an azetidin-2-one derivative (1a)
In the case of the compound (2) obtained by the deesterification / decarboxylation reaction, an α-alkyl compound (2α) can be selectively obtained. The configuration of the alkyl group at the 1-position of the carbapenem skeleton, which is the final product, is in the β-configuration. The obtained α-alkyl form (2α) is isomerized by the above-mentioned known method to give the β-alkyl form. (2β).

【0039】一方、原料化合物が、一般式(1)におい
てRがアミノ基の保護基である場合(以下、「アゼチ
ジン−2−オン誘導体(1b)」と記載する)には、前
記した脱エステル及び脱炭酸反応を行った後、当該アミ
ノ基の保護基を脱離せしめることにより、目的とする化
合物(2)を得ることができ、この場合は得られる化合
物(2)は、β−アルキル体(2β)が優先的に得られ
るので工業的利用価値が高く、好ましい。当該アミノ基
の保護基の脱離反応は、保護基の種類によって異なる
が、例えば保護基が三置換シリル基の場合には、希塩酸
のような酸を反応させればよい。また保護基が置換基を
有していてもよいベンジル基、フェネチル基、ベンズヒ
ドリル基等の場合には、バーチの還元により液体アンモ
ニア中で金属ナトリウムと反応させればよい。
On the other hand, when R 5 is a protecting group for an amino group in the general formula (1) (hereinafter referred to as “azetidin-2-one derivative (1b)”), After performing the esterification and decarboxylation reaction, the target compound (2) can be obtained by removing the protecting group of the amino group. In this case, the obtained compound (2) is a β-alkyl Since the body (2β) is preferentially obtained, the industrial utility value is high, which is preferable. The elimination reaction of the protecting group for the amino group differs depending on the type of the protecting group. For example, when the protecting group is a trisubstituted silyl group, an acid such as dilute hydrochloric acid may be reacted. In the case where the protecting group is a benzyl group, a phenethyl group, a benzhydryl group or the like which may have a substituent, it may be reduced with birch and reacted with metallic sodium in liquid ammonia.

【0040】[0040]

【実施例】次に参考例及び実施例を挙げて、本発明を更
に説明するが、本発明はこれらに限定されるものではな
い。なお、以下の測定には次の機器を用いた。 融点:MP−S3型(柳本商事株式会社製) 質量スペクトル(MS):M−80B質量分析計(イオ
ン化電圧:20eV)(株式会社日立製作所製) 赤外吸収スペクトル(IR):IR−810型(日本分
光工業株式会社製)1 H核磁気共鳴スペクトル(1H−NMR):AM−40
0型(400MHz)(ブルッカー社製) 内部標準物質:テトラメチルシラン
Next, the present invention will be further described with reference to Reference Examples and Examples, but the present invention is not limited thereto. The following equipment was used for the following measurements. Melting point: MP-S3 type (Yanagimoto Shoji Co., Ltd.) Mass spectrum (MS): M-80B mass spectrometer (ionization voltage: 20 eV) (Hitachi Ltd.) Infrared absorption spectrum (IR): IR-810 type (Manufactured by JASCO Corporation) 1 H nuclear magnetic resonance spectrum ( 1 H-NMR): AM-40
0 type (400MH z) (manufactured by Bruker) Internal standard substance: tetramethylsilane

【0041】参考例1Reference Example 1

【0042】[0042]

【化14】 Embedded image

【0043】(式中、Acは前記と同じ意味を示し、T
BDMSはtert−ブチルジメチルシリル基を示す。
以下同様)テトラヒドロフラン50mlに60%水素化
ナトリウム2.52g(62.9mmol)を懸濁さ
せ、室温で撹拌しながら、メチルマロン酸ジアリル(7
−1)11.88g(60.0mmol)をテトラヒド
ロフラン20mlに溶解した溶液を20分かけて滴下し
た。さらに、2.5時間撹拌した後、4−アセトキシア
ゼチジン−2−オン誘導体(4−1)14.35g(5
0.0mmol)をテトラヒドロフラン30mlに溶解
した溶液を15分かけて滴下し、室温で15時間反応を
続けた。反応液に飽和塩化アンモニウム水溶液30ml
を加え撹拌、分液した後、得られたテトラヒドロフラン
層を飽和食塩水で洗浄、無水硫酸マグネシウムで脱水
し、溶媒を留去して粗結晶23.5gを得た。ヘキサン
を用いて再結晶を行い、白色結晶のアゼチジン−2−オ
ン誘導体(1a−1)18.03g(収率85%)を得
た。 融点:82−82.5℃ MS(m/e):426(M+1),410,368 IR(KBr)cm−1:1765,1735 H−NMR δ(CDCl):0.07(s,6
H),0.88(s,9H),1.14(d,J=6.
3Hz,3H),1.50(s,3H),3.03
(m,1H),4.19(d,J=2.1Hz,1
H),4.21(m,1H),4.64(m,4H),
5.27(m,2H),5.34(m,2H),5.8
8(m,2H),5.96(broad s,1H)
(In the formula, Ac has the same meaning as described above.
BDMS represents a tert-butyldimethylsilyl group.
2.52 g (62.9 mmol) of 60% sodium hydride was suspended in 50 ml of tetrahydrofuran, and diallyl methylmalonate (7
-1) A solution obtained by dissolving 11.88 g (60.0 mmol) in 20 ml of tetrahydrofuran was added dropwise over 20 minutes. After further stirring for 2.5 hours, 14.35 g of the 4-acetoxyazetidin-2-one derivative (4-1) (5.
0.0mmol) in 30 ml of tetrahydrofuran was added dropwise over 15 minutes, and the reaction was continued at room temperature for 15 hours. 30 ml of saturated aqueous ammonium chloride solution
After stirring and liquid separation, the obtained tetrahydrofuran layer was washed with brine, dried over anhydrous magnesium sulfate, and the solvent was distilled off to obtain 23.5 g of crude crystals. Recrystallization was performed using hexane to obtain 18.03 g (yield: 85%) of azetidin-2-one derivative (1a-1) as white crystals. Mp: 82-82.5 ℃ MS (m / e ): 426 (M + +1), 410,368 IR (KBr) cm -1: 1765,1735 1 H-NMR δ (CDCl 3): 0.07 ( s, 6
H), 0.88 (s, 9H), 1.14 (d, J = 6.
3Hz, 3H), 1.50 (s, 3H), 3.03
(M, 1H), 4.19 (d, J = 2.1 Hz, 1
H), 4.21 (m, 1H), 4.64 (m, 4H),
5.27 (m, 2H), 5.34 (m, 2H), 5.8
8 (m, 2H), 5.96 (broad s, 1H)

【0044】参考例2Reference Example 2

【0045】[0045]

【化15】 Embedded image

【0046】60%水素化ナトリウム1.12g(2
8.0mmol)にヘキサン5mlを加え撹拌した後、傾斜法
によりヘキサンを除去した。この手順を数回繰り返すこ
とにより洗浄した後、テトラヒドロフラン20mlを加
え、室温で撹拌しながら、メチルマロン酸ジエチル(7
−2)4.52g(26.0mmol)をテトラヒドロフラ
ン20mlに溶解した溶液を15分かけて滴下した。さら
に、30分間撹拌した後、4−アセトキシアゼチジン−
2−オン誘導体(4−1)5.74g(20.0mmol)
をテトラヒドロフラン20mlに溶解した溶液を10分か
けて滴下し、室温で1時間反応を続けた。反応液に飽和
塩化アンモニウム水溶液25mlを加え撹拌、分液した
後、得られたテトラヒドロフラン層を飽和食塩水で洗
浄、無水硫酸マグネシウムで脱水し、溶媒を留去して粗
結晶を得た。ヘキサンを用いて再結晶を行い、白色結晶
のアゼチジン−2−オン誘導体(1a−2)6.17g
(収率77%)を得た。 融点;100.5-101℃ MS(m/e):402(M++1),386,344 IR(KBr)cm-1:1770,17351 H-NMR δ(CDCl3):0.07(s,6H),0.88(s,9H),1.14(d,J=6.
3Hz,3H),1.26,1.28(2overlapping t,J=7.1Hz,6H),1.46
(s,3H),3.01(m,1H),4.15(d,J=2.2Hz,1H),4.21(m,5H),5.
98(broad s,1H)
1.12 g of 60% sodium hydride (2
8.0 mmol), 5 ml of hexane was added and stirred, and then the hexane was removed by a gradient method. After washing by repeating this procedure several times, 20 ml of tetrahydrofuran was added, and while stirring at room temperature, diethyl methylmalonate (7 ml) was added.
-2) A solution of 4.52 g (26.0 mmol) in 20 ml of tetrahydrofuran was added dropwise over 15 minutes. After further stirring for 30 minutes, 4-acetoxyazetidine-
5.74 g (20.0 mmol) of 2-one derivative (4-1)
Was added dropwise over 10 minutes, and the reaction was continued at room temperature for 1 hour. To the reaction mixture was added 25 ml of a saturated aqueous solution of ammonium chloride, and the mixture was stirred and separated. The obtained tetrahydrofuran layer was washed with saturated saline and dried over anhydrous magnesium sulfate, and the solvent was distilled off to obtain crude crystals. Recrystallization was performed using hexane, and 6.17 g of an azetidin-2-one derivative (1a-2) as white crystals was obtained.
(77% yield). Melting point: 100.5-101 ° C MS (m / e): 402 (M + +1), 386,344 IR (KBr) cm -1 : 1770,1735 1 H-NMR δ (CDCl 3 ): 0.07 (s, 6H), 0.88 (s, 9H), 1.14 (d, J = 6.
3Hz, 3H), 1.26,1.28 (2overlapping t, J = 7.1Hz, 6H), 1.46
(s, 3H), 3.01 (m, 1H), 4.15 (d, J = 2.2Hz, 1H), 4.21 (m, 5H), 5.
98 (broad s, 1H)

【0047】参考例3Reference Example 3

【0048】[0048]

【化16】 Embedded image

【0049】(式中、Phはフェニル基を示す。以下同
様) テトラヒドロフラン5mlに60%水素化ナトリウム0.
43g(10.8mmol)を懸濁させ、室温で撹拌しなが
ら、メチルマロン酸ジベンジル(7−3)3.13g
(10.5mmol)をテトラヒドロフラン3mlに溶解した
溶液を20分かけて滴下した。さらに、室温で30分間
撹拌した後、4−アセトキシアゼチジン−2−オン誘導
体(4−1)2.87g(10.0mmol)をテトラヒド
ロフラン5mlに溶解した溶液を15分かけて滴下し、室
温で1.5時間反応を続けた。反応液に飽和塩化アンモ
ニウム水溶液15mlを加え撹拌した後、酢酸エチル20
mlを用いて抽出を行った。得られた酢酸エチル層を水洗
した後、無水硫酸マグネシウムで脱水し、次いで濃縮を
行って油状物を得た。これをシリカゲルカラムクロマト
グラフィー(展開溶媒;ヘキサン:酢酸エチル=4:
1)により精製して、白色結晶のアゼチジン−2−オン
誘導体(1a−3)4.28g(収率82%)を得た。 融点:93-93.5 ℃ MS(m/e):526(M++1),510,468 IR(KBr)cm-1:1770,17351 H-NMR δ(CDCl3):0.06(s,6H),0.87(s,9H),1.09(d,J=6.
4Hz,3H),1.50(s,3H),3.03(m,1H),4.19(m,1H),4.20(d,J=
2.1Hz,1H),5.11(m,4H),5.89(broad s,1H),7.23(m,4H),
7.32(m,6H)
(In the formula, Ph represents a phenyl group; the same applies hereinafter.) In 5 ml of tetrahydrofuran, 0.1% of 60% sodium hydride was added.
43 g (10.8 mmol) were suspended and, while stirring at room temperature, 3.13 g of dibenzyl methylmalonate (7-3)
A solution of (10.5 mmol) in 3 ml of tetrahydrofuran was added dropwise over 20 minutes. Further, after stirring at room temperature for 30 minutes, a solution of 2.87 g (10.0 mmol) of the 4-acetoxyazetidin-2-one derivative (4-1) dissolved in 5 ml of tetrahydrofuran was added dropwise over 15 minutes. The reaction was continued for 1.5 hours. To the reaction mixture was added 15 ml of a saturated aqueous solution of ammonium chloride, and the mixture was stirred.
Extraction was performed using ml. The obtained ethyl acetate layer was washed with water, dried over anhydrous magnesium sulfate, and then concentrated to obtain an oily substance. This was subjected to silica gel column chromatography (developing solvent; hexane: ethyl acetate = 4:
Purification according to 1) gave 4.28 g (82% yield) of azetidin-2-one derivative (1a-3) as white crystals. Melting point: 93-93.5 ° C MS (m / e): 526 (M + +1), 510,468 IR (KBr) cm -1 : 1770,1735 1 H-NMR δ (CDCl 3 ): 0.06 (s, 6H), 0.87 (s, 9H), 1.09 (d, J = 6.
4Hz, 3H), 1.50 (s, 3H), 3.03 (m, 1H), 4.19 (m, 1H), 4.20 (d, J =
2.1Hz, 1H), 5.11 (m, 4H), 5.89 (broad s, 1H), 7.23 (m, 4H),
7.32 (m, 6H)

【0050】参考例4Reference Example 4

【0051】[0051]

【化17】 Embedded image

【0052】テトラヒドロフラン15mlに60%水素化
ナトリウム2.17g(54.3mmol)を懸濁させ、室
温で撹拌しながら、メチルマロン酸tert−ブチルエ
チル(7−4)10.9g(54.0mmol)をテトラヒ
ドロフラン20mlに溶解した溶液を1時間かけて滴下し
た。さらに、室温で30分間撹拌した後、4−アセトキ
シアゼチジン−2−オン誘導体(4−1)14.1g
(49.1mmol)をテトラヒドロフラン30mlに溶解し
た溶液を20分かけて滴下し、室温で一晩反応を続け
た。反応液に飽和塩化アンモニウム水溶液50mlを加え
撹拌した後、酢酸エチル50mlを用いて抽出を行った。
得られた酢酸エチル層を飽和食塩水25mlで2回洗浄し
た後、無水硫酸マグネシウムで脱水し、次いで濾過、濃
縮を行って粗生成物を得た。これをシリカゲルカラムク
ロマトグラフィー(展開溶媒;ヘキサン:酢酸エチル=
4:1)により精製して、白色結晶のアゼチジン−2−
オン誘導体(1a−4)及び(1a−5)の異性体混合
物〔混合比(1a−4):(1a−5)=77:23〕
14.2g(収率67%)を得た。 融点:73-74℃ MS(m/e):414,372 IR(KBr)cm-1:1765,17351 H-NMR δ(CDCl3):0.07(s,3H),0.08(s,3H),0.89(s,9H)
1.15(d,J=6.4Hz,3H×23/100),1.20(d,J=6.3Hz,3H×77/1
00),1.27(d,J=7.1Hz,3H×77/100),1.29(d,J=7.1Hz,3H×
23/100),1.41(s,3H×23/100),1.42(s,3H×77/100),1.45
(s,9H×23/100),1.47(s,9H×77/100),2.98(m,1H×23/10
0),3.02(m,1H×77/100),4.04(d,J=2.1Hz,1H×77/100),
4.09(d,J=2.2Hz,1H×23/100),4.20(m,3H),5.97(broad
s,1H)
A suspension of 2.17 g (54.3 mmol) of 60% sodium hydride in 15 ml of tetrahydrofuran was added with 10.9 g (54.0 mmol) of tert-butylethyl methylmalonate (7-4) at room temperature while stirring. A solution dissolved in 20 ml of tetrahydrofuran was added dropwise over 1 hour. Furthermore, after stirring at room temperature for 30 minutes, 14.1 g of 4-acetoxyazetidin-2-one derivative (4-1) was obtained.
A solution of (49.1 mmol) dissolved in 30 ml of tetrahydrofuran was added dropwise over 20 minutes, and the reaction was continued at room temperature overnight. After adding 50 ml of a saturated aqueous solution of ammonium chloride to the reaction solution and stirring, extraction was performed using 50 ml of ethyl acetate.
The obtained ethyl acetate layer was washed twice with 25 ml of saturated saline, dried over anhydrous magnesium sulfate, filtered and concentrated to obtain a crude product. This was subjected to silica gel column chromatography (developing solvent; hexane: ethyl acetate =
4: 1) to give azetidine-2- white crystals.
An isomer mixture of the on derivatives (1a-4) and (1a-5) [mixing ratio (1a-4) :( 1a-5) = 77: 23]
14.2 g (67% yield) was obtained. Melting point: 73-74 ° C MS (m / e): 414,372 IR (KBr) cm -1 : 1765,1735 1 H-NMR δ (CDCl 3 ): 0.07 (s, 3H), 0.08 (s, 3H), 0.89 (s, 9H)
1.15 (d, J = 6.4Hz, 3H × 23/100), 1.20 (d, J = 6.3Hz, 3H × 77/1
00), 1.27 (d, J = 7.1Hz, 3H × 77/100), 1.29 (d, J = 7.1Hz, 3H ×
23/100), 1.41 (s, 3H × 23/100), 1.42 (s, 3H × 77/100), 1.45
(s, 9H × 23/100), 1.47 (s, 9H × 77/100), 2.98 (m, 1H × 23/10
0), 3.02 (m, 1H × 77/100), 4.04 (d, J = 2.1Hz, 1H × 77/100),
4.09 (d, J = 2.2Hz, 1H × 23/100), 4.20 (m, 3H), 5.97 (broad
s, 1H)

【0053】参考例5Reference Example 5

【0054】[0054]

【化18】 Embedded image

【0055】60%水素化ナトリウム0.30g(7.
5mmol)にヘキサン3mlを加え撹拌した後、傾斜法によ
りヘキサンを除去した。これにテトラヒドロフラン3.
5mlを加え、室温で撹拌しながら、メチルマロン酸ジ−
(1)−メンチル(7−5)2.96g(7.5mmol)
をテトラヒドロフラン5mlに溶解した溶液を15分かけ
て滴下した。さらに、室温で30分間撹拌した後、4−
アセトキシアゼチジン−2−オン誘導体(4−1)2.
01g(7.0mmol)をテトラヒドロフラン5mlに溶解
した溶液を10分かけて滴下し、室温で1時間反応を続
けた。反応液に飽和塩化アンモニウム水溶液10mlを加
え撹拌、分液した後、テトラヒドロフラン層を飽和食塩
水で洗浄し、次いで無水硫酸マグネシウムで脱水し、溶
媒を留去して粗生成物を得た。これをシリカゲルカラム
クロマトグラフィー(展開溶媒;ヘキサン:酢酸エチル
=8:1)により精製して、無色油状のアゼチジン−2
−オン誘導体(1a−6)2.94g(収率68%)を
得た。 MS(m/e):622(M++1),564 IR(neat)cm-1:1770,1740,17201 H-NMR δ(CDCl3):0.07(s,3H),0.08(s,3H),0.72(d,J=7.
0Hz,3H),0.77(d,J=7.0Hz,3H),0.88(s,9H),0.91(d,J=6.7
Hz,6H),0.92(d,J=6.5Hz,6H),0.95(m,6H),1.22(d,J=6.3H
z,3H),1.42(m,4H),1.45(s,3H),1.70(m,4H),1.86(m,2H),
2.03(m,2H),3.10(m,1H),4.06(d,J=2.2Hz,1H),4.22(m,1
H),4.73(m,2H),5.91(s,1H)
0.30 g of 60% sodium hydride (7.
5 mmol), and 3 ml of hexane was added and stirred, and then hexane was removed by a gradient method. To this, tetrahydrofuran 3.
Add 5 ml, and stir at room temperature.
2.96 g (7.5 mmol) of (1) -menthyl (7-5)
Was dissolved dropwise in 5 ml of tetrahydrofuran over 15 minutes. After stirring at room temperature for 30 minutes,
1. Acetoxyazetidin-2-one derivative (4-1)
A solution of 01 g (7.0 mmol) in 5 ml of tetrahydrofuran was added dropwise over 10 minutes, and the reaction was continued at room temperature for 1 hour. 10 ml of a saturated aqueous ammonium chloride solution was added to the reaction solution, and the mixture was stirred and separated. The tetrahydrofuran layer was washed with saturated saline and then dried over anhydrous magnesium sulfate, and the solvent was distilled off to obtain a crude product. This was purified by silica gel column chromatography (developing solvent; hexane: ethyl acetate = 8: 1) to give azetidine-2 as a colorless oil.
2.94 g (68% yield) of the -one derivative (1a-6) was obtained. MS (m / e): 622 (M + +1), 564 IR (neat) cm -1: 1770,1740,1720 1 H-NMR δ (CDCl 3): 0.07 (s, 3H), 0.08 (s, 3H), 0.72 (d, J = 7.
0Hz, 3H), 0.77 (d, J = 7.0Hz, 3H), 0.88 (s, 9H), 0.91 (d, J = 6.7
Hz, 6H), 0.92 (d, J = 6.5Hz, 6H), 0.95 (m, 6H), 1.22 (d, J = 6.3H
z, 3H), 1.42 (m, 4H), 1.45 (s, 3H), 1.70 (m, 4H), 1.86 (m, 2H),
2.03 (m, 2H), 3.10 (m, 1H), 4.06 (d, J = 2.2Hz, 1H), 4.22 (m, 1H
H), 4.73 (m, 2H), 5.91 (s, 1H)

【0056】参考例6Reference Example 6

【0057】[0057]

【化19】 Embedded image

【0058】テトラヒドロフラン50mlに60%水素化
ナトリウム2.92g(73.0mmol)を懸濁させ、室
温で攪拌しながら、n−プロピルマロン酸ジアリル(7
−6)33.07g(73.0mmol)をテトラヒドロフ
ラン50mlに溶解した溶液を滴下した。2.5時間攪拌
した後、4−アセトキシアゼチジン−2−オン誘導体
(4−1)20.10g(70.0mmol)をテトラヒド
ロフラン50mlに溶解した溶液を30分かけて滴下し、
室温で15時間反応を続けた。反応液に飽和塩化アンモ
ニウム水溶液60mlを加え攪拌、分液した後、得られた
テトラヒドロフラン層を飽和食塩水で洗浄、無水硫酸マ
グネシウムで脱水し、溶媒を留去して粗生成物を得た。
これをシリカゲルカラムクロマトグラフィー(展開溶
媒;ヘキサン:酢酸エチル=10:1)により精製し
て、白色結晶のアゼチジン−2−オン誘導体(1a−
7)26.32g(収率83%)を得た。 融点:47-48℃ MS(m/e):438,396 IR(KBr)cm-1:1770,17301 H-NMR δ(CDCl3):0.07(s,6H),0.88(s,9H),0.94(t,J=7.
3Hz,3H),1.17(d,J=6.4Hz,3H),1.25(m,1H),1.47(m,1H),
1.80(ddd,J=4.4,12.5,14.0Hz,1H),1.97(ddd,J=4.6,12.
7,14.0Hz,1H),3.08(m,1H),4.25(m,2H),4.65(m,4H),5.30
(m,4H),5.88(m,3H)
2.92 g (73.0 mmol) of 60% sodium hydride were suspended in 50 ml of tetrahydrofuran, and diallyl n-propylmalonate (7
-6) A solution of 33.07 g (73.0 mmol) in 50 ml of tetrahydrofuran was added dropwise. After stirring for 2.5 hours, a solution of 20.10 g (70.0 mmol) of the 4-acetoxyazetidin-2-one derivative (4-1) in 50 ml of tetrahydrofuran was added dropwise over 30 minutes.
The reaction was continued at room temperature for 15 hours. After adding 60 ml of a saturated aqueous solution of ammonium chloride to the reaction solution and stirring and separating the resulting solution, the obtained tetrahydrofuran layer was washed with saturated saline and dried over anhydrous magnesium sulfate, and the solvent was distilled off to obtain a crude product.
This was purified by silica gel column chromatography (developing solvent; hexane: ethyl acetate = 10: 1) to give an azetidin-2-one derivative (1a-) as white crystals.
7) 26.32 g (83% yield) was obtained. Melting point: 47-48 ° C MS (m / e): 438,396 IR (KBr) cm -1 : 1770,1730 1 H-NMR δ (CDCl 3 ): 0.07 (s, 6H), 0.88 (s, 9H), 0.94 (t, J = 7.
3Hz, 3H), 1.17 (d, J = 6.4Hz, 3H), 1.25 (m, 1H), 1.47 (m, 1H),
1.80 (ddd, J = 4.4,12.5,14.0Hz, 1H), 1.97 (ddd, J = 4.6,12.
7,14.0Hz, 1H), 3.08 (m, 1H), 4.25 (m, 2H), 4.65 (m, 4H), 5.30
(m, 4H), 5.88 (m, 3H)

【0059】参考例7Reference Example 7

【0060】[0060]

【化20】 Embedded image

【0061】N,N−ジメチルホルムアミド20mlに参
考例1で得られたアゼチジン−2−オン誘導体(1a−
1)8.50g(20.0mmol)及びtert−ブチル
ジメチルシリルクロライド6.04g(40.0mmol)
を溶解し、トリエチルアミン6.06g(60.0mmo
l)をN,N−ジメチルホルムアミド5mlに溶解した溶
液を室温で15分かけて滴下した。さらに4時間撹拌し
た後、4−N,N−ジメチルアミノピリジン0.12g
(1.0mmol)を加えて室温で6日間反応させた。反応
液を減圧濃縮した後、水40mlを加えジエチルエーテル
200mlを用いて抽出を行った。得られたジエチルエー
テル層を飽和食塩水30mlで洗浄した後、無水硫酸マグ
ネシウムで脱水し、次いで溶媒を留去して粗生成物を得
た。これをアルミナカムラクロマトグラフィー(展開溶
媒;ヘキサン:酢酸エチル=9:1〜8:2)により精
製して、無色油状のアゼチジン−2−オン誘導体(1b
−1)8.02g(収率74%)を得た。 MS(m/e):540(M++1),524,482 IR(neat)cm-1:1760,17401 H-NMR δ(CDCl3):0.07(s,3H),0.08(s,3H),0.11(s,3H),
0.29(s,3H),0.89(s,9H),0.96(s,9H),1.22(d,J=6.2Hz,3
H),1.50(s,3H),3.07(dd,J=2.6,6.8Hz,1H),4.09(m,1H),
4.35(d,J=2.6Hz,1H),4.64(m,4H),5.30(m,4H),5.90(m,2
H)
In 20 ml of N, N-dimethylformamide, the azetidin-2-one derivative (1a-
1) 8.50 g (20.0 mmol) and tert-butyldimethylsilyl chloride 6.04 g (40.0 mmol)
Was dissolved, and 6.06 g (60.0 mmol) of triethylamine was dissolved.
A solution of l) in 5 ml of N, N-dimethylformamide was added dropwise at room temperature over 15 minutes. After further stirring for 4 hours, 0.12 g of 4-N, N-dimethylaminopyridine
(1.0 mmol) was added and reacted at room temperature for 6 days. After the reaction solution was concentrated under reduced pressure, 40 ml of water was added and extraction was performed using 200 ml of diethyl ether. The obtained diethyl ether layer was washed with 30 ml of saturated saline, dried over anhydrous magnesium sulfate, and then the solvent was distilled off to obtain a crude product. This was purified by alumina camula chromatography (developing solvent; hexane: ethyl acetate = 9: 1 to 8: 2) to give a colorless oily azetidin-2-one derivative (1b
-1) 8.02 g (74% yield) was obtained. MS (m / e): 540 (M + +1), 524,482 IR (neat) cm -1 : 1760,1740 1 H-NMR δ (CDCl 3 ): 0.07 (s, 3H), 0.08 (s, 3H) , 0.11 (s, 3H),
0.29 (s, 3H), 0.89 (s, 9H), 0.96 (s, 9H), 1.22 (d, J = 6.2Hz, 3
H), 1.50 (s, 3H), 3.07 (dd, J = 2.6,6.8Hz, 1H), 4.09 (m, 1H),
4.35 (d, J = 2.6Hz, 1H), 4.64 (m, 4H), 5.30 (m, 4H), 5.90 (m, 2
H)

【0062】参考例8Reference Example 8

【0063】[0063]

【化21】 Embedded image

【0064】N,N−ジメチルホルムアミド5mlに60
%水素化ナトリウム0.19g(4.8mmol)を懸濁さ
せ、0℃に冷却し、参考例1で得られたアゼチジン−2
−オン誘導体(1a−1)1.93g(4.5mmol)を
N,N−ジメチルホルムアミド5mlに溶解した溶液を1
0分かけて滴下した。さらに、30分間撹拌した後、室
温に戻し、塩化ベンジル0.58g(4.6mmol)を滴
下し、4時間反応を続けた。反応液に飽和塩化アンモニ
ウム水溶液5mlを加え、ジエチルエーテル50mlで抽出
した。得られたジエチルエーテル層を無水硫酸マグネシ
ウムで脱水した後、溶媒を留去して粗生成物を得た。こ
れをシリカゲルカラムクロマトグラフィー(展開溶媒;
ヘキサン:酢酸エチル=4:1)により精製して、無色
油状のアゼチジン−2−オン誘導体(1b−2)1.5
7g(収率68%)を得た。 MS(m/e):516(M++1),500,458 IR(neat)cm-1:1760,17401 H-NMR δ(CDCl3):-0.01(s,3H),0.05(s,3H),0.85(s,9
H),1.13(d,J=6.3Hz,3H),1.31(s,3H),2.99(m,1H),4.18
(m,1H),4.23(d,J=15.4Hz,1H),4.38(d,J=2.1Hz,1H),4.57
(m,5H),5.28(m,4H),5.83(m,2H),7.31(m,5H)
60 ml of 5 ml of N, N-dimethylformamide
0.19 g (4.8 mmol) of sodium hydride was cooled to 0 ° C., and the azetidine-2 obtained in Reference Example 1 was suspended in the suspension.
A solution obtained by dissolving 1.93 g (4.5 mmol) of the -one derivative (1a-1) in 5 ml of N, N-dimethylformamide was added to 1
It was added dropwise over 0 minutes. After further stirring for 30 minutes, the temperature was returned to room temperature, 0.58 g (4.6 mmol) of benzyl chloride was added dropwise, and the reaction was continued for 4 hours. To the reaction solution was added 5 ml of a saturated aqueous solution of ammonium chloride, and the mixture was extracted with 50 ml of diethyl ether. After the obtained diethyl ether layer was dehydrated with anhydrous magnesium sulfate, the solvent was distilled off to obtain a crude product. This was subjected to silica gel column chromatography (developing solvent;
Hexane: ethyl acetate = 4: 1) to give a colorless oily azetidin-2-one derivative (1b-2).
7 g (68% yield) were obtained. MS (m / e): 516 (M + +1), 500,458 IR (neat) cm -1 : 1760,1740 1 H-NMR δ (CDCl 3 ): -0.01 (s, 3H), 0.05 (s, 3H) ), 0.85 (s, 9
H), 1.13 (d, J = 6.3Hz, 3H), 1.31 (s, 3H), 2.99 (m, 1H), 4.18
(m, 1H), 4.23 (d, J = 15.4Hz, 1H), 4.38 (d, J = 2.1Hz, 1H), 4.57
(m, 5H), 5.28 (m, 4H), 5.83 (m, 2H), 7.31 (m, 5H)

【0065】参考例9Reference Example 9

【0066】[0066]

【化22】 Embedded image

【0067】参考例1で得られたアゼチジン−2−オン
誘導体(1a−1)2.13g(5.0mmol)、60%
水素化ナトリウム0.24g(6.0mmol)及び塩化p
−メトキシベンジル0.94g(6.0mmol)を用い
て、前記参考例8に従ってN−ベンジル化を行い、無色
油状のアゼチジン−2−オン誘導体(1b−3)2.0
7g(収率76%)を得た。 MS(m/e):488 IR(neat)cm-1:1760,17351 H-NMR δ(CDCl3):0.01(s,3H),0.05(s,3H),0.85(s,9H),
1.13(d,J=6.3Hz,3H),1.30(s,3H),2.98(dd,J=2.1,4.3Hz,
1H),3.79(s,3H),4.16(m,1H),4.18(d,J=15.2Hz,1H),4.37
(d,J=2.1Hz,1H),4.43(d,J=15.2Hz,1H),4.59(m,4H),5.28
(m,4H),5.82(m,2H),6.83(dd,J=2.1,6.3Hz,2H),7.27(dd,
J=2.1,6.3Hz,2H)
2.13 g (5.0 mmol) of the azetidin-2-one derivative (1a-1) obtained in Reference Example 1, 60%
0.24 g (6.0 mmol) of sodium hydride and p chloride
N-benzylation was carried out using 0.94 g (6.0 mmol) of -methoxybenzyl according to the above Reference Example 8 to give a colorless oily azetidin-2-one derivative (1b-3) 2.0
7 g (76% yield) were obtained. MS (m / e): 488 IR (neat) cm -1 : 1760,1735 1 H-NMR δ (CDCl 3 ): 0.01 (s, 3H), 0.05 (s, 3H), 0.85 (s, 9H),
1.13 (d, J = 6.3Hz, 3H), 1.30 (s, 3H), 2.98 (dd, J = 2.1,4.3Hz,
1H), 3.79 (s, 3H), 4.16 (m, 1H), 4.18 (d, J = 15.2Hz, 1H), 4.37
(d, J = 2.1Hz, 1H), 4.43 (d, J = 15.2Hz, 1H), 4.59 (m, 4H), 5.28
(m, 4H), 5.82 (m, 2H), 6.83 (dd, J = 2.1,6.3Hz, 2H), 7.27 (dd,
(J = 2.1,6.3Hz, 2H)

【0068】参考例10Reference Example 10

【0069】[0069]

【化23】 Embedded image

【0070】参考例2で得られたアゼチジン−2−オン
誘導体(1a−2)4.01g(10.0mmol)、
60%水素化ナトリウム0.40g(11.0mmo
l)及び塩化ベンジル1.39g(11.0mmol)
を用いて、前記参考例8に従ってN−ベンジル化を行
い、無色油状のアゼチジン−2−オン誘導体(1b−
4)4.30g(収率88%)を得た。 MS(m/e):476,434 IR(neat)cm−1:1760,1730 H−NMR δ(CDCl):0.00(s,3
H),0.06(s,3H),0.87(s,9H),
1.16(d,J=6.3Hz,3H),1.20,
1.22(2overlapping t,J=7.3
Hz,6H),1.30(s,3H),2.99(d
d,J=2.1,4.5Hz,1H),4.17(m,
6H),4.36(d,J=2.1Hz,1H),4.
55(d,J=15.3Hz,1H),7.31(m,
5H)
The azetidin-2-one derivative (1a-2) obtained in Reference Example 2 (4.01 g, 10.0 mmol),
0.40 g of 60% sodium hydride (11.0 mmo
l) and 1.39 g (11.0 mmol) of benzyl chloride
Was subjected to N-benzylation according to the above Reference Example 8 to give a colorless oily azetidin-2-one derivative (1b-
4) 4.30 g (88% yield) was obtained. MS (m / e): 476,434 IR (neat) cm -1: 1760,1730 1 H-NMR δ (CDCl 3): 0.00 (s, 3
H), 0.06 (s, 3H), 0.87 (s, 9H),
1.16 (d, J = 6.3 Hz, 3H), 1.20,
1.22 (2 overlapping t, J = 7.3
Hz, 6H), 1.30 (s, 3H), 2.99 (d
d, J = 2.1, 4.5 Hz, 1H), 4.17 (m,
6H), 4.36 (d, J = 2.1 Hz, 1H), 4.
55 (d, J = 15.3 Hz, 1H), 7.31 (m,
5H)

【0071】実施例1Embodiment 1

【0072】[0072]

【化24】 Embedded image

【0073】アルゴン気流下、酢酸パラジウム4.8m
g(0.02mmol)を1,4−ジオキサン2mlに
懸濁させ、これにトリフェニルホスフィン52.0mg
(0.2mmol)を1,4−ジオキサン2mlに溶解
した溶液を滴下した後、加熱還流し、さらに参考例1で
得られたアゼチジン−2−オン誘導体(1a−1)0.
85g(2.0mmol)、ギ酸0.37g(8.0m
mol)及びトリエチルアミン0.81g(8.0mm
ol)を1,4−ジオキサン6mlに溶解した溶液を滴
下し、3時間反応させた。反応液に5%水酸化ナトリウ
ム水溶液10ml及び酢酸エチル10mlを加えて分液
し、水層を1N塩酸で酸性にした後、酢酸エチル20m
lで抽出した。得られた酢酸エチル層を無水硫酸マグネ
シウムで脱水した後、溶媒を留去して、白色結晶の目的
化合物4−(1−カルボキシエチル)−アゼチジン−2
−オン誘導体(2−1)0.47g(収率78%)を得
た。なお、得られた化合物(2−1)の式中波線のメチ
ル基がα位である化合物(2α−1)とβ位である化合
物(2β−1)の生成比はα:β=85:15であり、
これらは高速液体クロマトグラフィー(HPLC)(カ
ラム;Inertsil ODS、ジーエルサイエンス
株式会社製、展開溶媒;アセトニトリル:水:酢酸=7
00:300:3)で分離し、構造を決定した。 α体(2α−1) 融点:168−170℃ MS(m/e):286,244 IR(KBr)cm−1:1720 H−NMR δ(CDCl):0.07(s,3
H),0.08(s,3H),0.88(s,9H),
1.25(2overlapping d,J=6.
2,7.3Hz,6H),2.56(qd,J=7.
3,9.8Hz,1H),2.80(dd,J=2.
0,5.3Hz,1H),3.70(dd,J=2.
0,9.8Hz,1H),4.19(m,1H),6.
67(broads,1H) β体(2β−1) 融点:143.5−144.5℃ MS(m/e):286,244 IR(KBr)cm−1:1720 H−NMR δ(CDCl):0.07(s,3
H),0.08(s,3H),0.87(s,9H),
1.20(d,J=6.3Hz,3H),1.27
(d,J=7.0Hz,3H),2.75(qd,J=
5.0,7.0Hz,1H),3.03(dd,J=
2.2,4.3Hz,1H),3.94(dd,J=
2.2,5.0Hz,1H),4.20(qd,J=
4.5,6.3Hz,1H),6.25(broad
s,1H)
4.8 m of palladium acetate in a stream of argon
g (0.02 mmol) was suspended in 2 ml of 1,4-dioxane, and 52.0 mg of triphenylphosphine was added thereto.
(0.2 mmol) dissolved in 2 ml of 1,4-dioxane was added dropwise, and the mixture was heated under reflux, and then the azetidin-2-one derivative (1a-1) obtained in Reference Example 1 was added.
85 g (2.0 mmol), formic acid 0.37 g (8.0 m
mol) and 0.81 g (8.0 mm) of triethylamine.
ol) in 6 ml of 1,4-dioxane was added dropwise and reacted for 3 hours. 10 ml of a 5% aqueous solution of sodium hydroxide and 10 ml of ethyl acetate were added to the reaction solution, and the mixture was separated.
Extracted with l. After the obtained ethyl acetate layer was dehydrated with anhydrous magnesium sulfate, the solvent was distilled off, and the target compound 4- (1-carboxyethyl) -azetidine-2 was obtained as white crystals.
0.47 g (78% yield) of the -one derivative (2-1) was obtained. The formation ratio of the compound (2α-1) in which the methyl group of the wavy line in the formula of the obtained compound (2-1) is α-position and the compound (2β-1) in which the methyl group is β-position is α: β = 85: 15 and
These are high performance liquid chromatography (HPLC) (column: Inertsil ODS, manufactured by GL Sciences Inc., developing solvent: acetonitrile: water: acetic acid = 7)
00: 300: 3) and the structure was determined. α body (2α-1) mp: 168-170 ℃ MS (m / e ): 286,244 IR (KBr) cm -1: 1720 1 H-NMR δ (CDCl 3): 0.07 (s, 3
H), 0.08 (s, 3H), 0.88 (s, 9H),
1.25 (2 overlapping d, J = 6.
2,7.3 Hz, 6H), 2.56 (qd, J = 7.
3,9.8 Hz, 1H), 2.80 (dd, J = 2.
0, 5.3 Hz, 1H), 3.70 (dd, J = 2.
0, 9.8 Hz, 1H), 4.19 (m, 1H), 6.
67 (broads, 1H) β body (2β-1) mp: 143.5-144.5 ℃ MS (m / e ): 286,244 IR (KBr) cm -1: 1720 1 H-NMR δ (CDCl 3 ): 0.07 (s, 3
H), 0.08 (s, 3H), 0.87 (s, 9H),
1.20 (d, J = 6.3 Hz, 3H), 1.27
(D, J = 7.0 Hz, 3H), 2.75 (qd, J =
5.0, 7.0 Hz, 1H), 3.03 (dd, J =
2.2, 4.3 Hz, 1H), 3.94 (dd, J =
2.2, 5.0 Hz, 1H), 4.20 (qd, J =
4.5, 6.3 Hz, 1H), 6.25 (broad)
s, 1H)

【0074】実施例2Embodiment 2

【0075】[0075]

【化25】 Embedded image

【0076】窒素雰囲気下、酢酸パラジウム9.0mg
(0.04mmol)及びトリフェニルホスフィン53.0
mg(0.20mmol)を1,4−ジオキサン8mlに溶解し
た溶液に、ギ酸746.0mg(16.22mmol)及びト
リエチルアミン1647.7mg(16.31mmol)を
1,4−ジオキサン10mlに溶解した溶液を加え、加熱
還流した。これに参考例6で得られたアゼチジン−2−
オン誘導体(1a−7)1815.4mg(4.01mmo
l)を1,4−ジオキサン5mlに溶解した溶液を40分
かけて滴下し、さらに5時間加熱還流を続けた。反応液
を室温まで冷却し、ジエチルエーテル15mlと5%水酸
化ナトリウム水溶液20mlで抽出した後、アルカリ層に
2N塩酸を加えてpH2とし、酢酸エチル35mlで2回抽
出を行った。得られた酢酸エチル層を飽和食塩水で洗浄
後、無水硫酸マグネシウムで脱水、次いで濾過、濃縮を
行って、白色結晶の目的化合物4−(1−カルボキシブ
チル)−アゼチジン−2−オン誘導体(2−2)98
5.8mg(収率75%)を得た。なお、得られた化合物
(2−2)の式中波線のn−プロピル基がα位である化
合物(2α−2)とβ位である化合物(2β−2)の生
成比はα:β=73:27であり、これらはHPLC
(カラム及び展開溶媒の条件は実施例1と同じ)で分離
し、構造を決定した。 α体(2α−2) 融点:173-174℃ MS(m/e):314,272 IR(KBr)cm-1:17201 H-NMR δ(CD3OD):0.08(s,3H),0.10(s,3H),0.90(s,9H),
0.94(t,J=7.2Hz,3H),1.23(d,J=6.3Hz,3H),1.40(m,2H),
1.60(m,2H),2.47(m,1H),2.88(dd,J=2.0,4.3Hz,1H),3.78
(dd,J=2.0,8.7Hz,1H),4.20(qd,J=4.3,6.3Hz,1H) β体(2β−2) 融点:164.5-166℃ MS(m/e):314,272 IR(KBr)cm-1:17201 H-NMR δ(CD3OD):0.07(s,3H),0.08(s,3H),0.89(s,9H),
0.95(t,J=7.2Hz,3H),1.16(d,J=6.4Hz,3H),1.45(m,3H),
1.64(m,1H),2.48(m,1H),3.01(dd,J=2.0,2.7Hz,1H),3.77
(dd,J=2.0,8.4Hz,1H),4.22(qd,J=2.7,6.4Hz,1H)
Under a nitrogen atmosphere, 9.0 mg of palladium acetate
(0.04 mmol) and triphenylphosphine 53.0
mg (0.20 mmol) in 8 ml of 1,4-dioxane was dissolved in a solution of 746.0 mg (16.22 mmol) of formic acid and 1647.7 mg (16.31 mmol) of triethylamine in 10 ml of 1,4-dioxane. In addition, the mixture was heated to reflux. In addition, azetidine-2- obtained in Reference Example 6
1815.4 mg (4.01 mmol) of the on derivative (1a-7)
A solution of l) dissolved in 5 ml of 1,4-dioxane was added dropwise over 40 minutes, and the mixture was further heated under reflux for 5 hours. The reaction solution was cooled to room temperature, extracted with 15 ml of diethyl ether and 20 ml of a 5% aqueous sodium hydroxide solution, adjusted to pH 2 by adding 2N hydrochloric acid to the alkaline layer, and extracted twice with 35 ml of ethyl acetate. The obtained ethyl acetate layer was washed with a saturated saline solution, dehydrated with anhydrous magnesium sulfate, filtered and concentrated to obtain the target compound 4- (1-carboxybutyl) -azetidin-2-one derivative (2) as white crystals. -2) 98
5.8 mg (75% yield) were obtained. The formation ratio of the compound (2α-2) in which the n-propyl group of the wavy line in the formula of the obtained compound (2-2) is α-position and the compound (2β-2) in which β-position is obtained is α: β = 73:27, which are HPLC
(The conditions of the column and the developing solvent were the same as in Example 1), and the structure was determined. α body (2α-2) mp: 173-174 ℃ MS (m / e ): 314,272 IR (KBr) cm -1: 1720 1 H-NMR δ (CD 3 OD): 0.08 (s, 3H), 0.10 ( s, 3H), 0.90 (s, 9H),
0.94 (t, J = 7.2Hz, 3H), 1.23 (d, J = 6.3Hz, 3H), 1.40 (m, 2H),
1.60 (m, 2H), 2.47 (m, 1H), 2.88 (dd, J = 2.0,4.3Hz, 1H), 3.78
(dd, J = 2.0,8.7Hz, 1H), 4.20 (qd, J = 4.3,6.3Hz, 1H) β-isomer (2β-2) Melting point: 164.5-166 ° C MS (m / e): 314,272 IR (KBr ) cm -1: 1720 1 H- NMR δ (CD 3 OD): 0.07 (s, 3H), 0.08 (s, 3H), 0.89 (s, 9H),
0.95 (t, J = 7.2Hz, 3H), 1.16 (d, J = 6.4Hz, 3H), 1.45 (m, 3H),
1.64 (m, 1H), 2.48 (m, 1H), 3.01 (dd, J = 2.0,2.7Hz, 1H), 3.77
(dd, J = 2.0,8.4Hz, 1H), 4.22 (qd, J = 2.7,6.4Hz, 1H)

【0077】実施例3Embodiment 3

【0078】[0078]

【化26】 Embedded image

【0079】窒素雰囲気下、酢酸パラジウム4.5mg
(0.02mmol)及びトリフェニルホスフィン10.5
mg(0.04mmol)をトルエン2.5mlに溶解した溶液
に、ギ酸0.56g(12.0mmol)を加え70℃で加
熱撹拌した。この反応液に参考例7で得られたアゼチジ
ン−2−オン誘導体(1b−1)0.54g(1.0mm
ol)をトルエン2mlに溶解した溶液を15分かけて滴下
し、さらに70℃で3.5時間撹拌を続けた。反応液を
室温まで冷却し、ジエチルエーテル15ml及び2N塩酸
5mlを加え、20分間撹拌した後、分液を行った。ジエ
チルエーテル層を5%水酸化ナトリウム水溶液10mlで
3回抽出した後、水層に2N塩酸を加えてpH2とし、ジ
エチルエーテル20mlで2回抽出を行った。得られたジ
エチルエーテル層を飽和食塩水で洗浄後、無水硫酸マグ
ネシウムで脱水、次いで濾過、濃縮を行って、目的とす
る化合物(2−1)0.23g(収率76%)を得た。
なお、得られた化合物(2−1)の異性体生成比は、
(2α−1):(2β−1)=6:94であった。
Under a nitrogen atmosphere, 4.5 mg of palladium acetate
(0.02 mmol) and 10.5 triphenylphosphine
0.56 g (12.0 mmol) of formic acid was added to a solution of mg (0.04 mmol) dissolved in 2.5 ml of toluene, and the mixture was heated and stirred at 70 ° C. 0.54 g (1.0 mm) of the azetidin-2-one derivative (1b-1) obtained in Reference Example 7 was added to the reaction solution.
ol) in 2 ml of toluene was added dropwise over 15 minutes, and stirring was continued at 70 ° C. for 3.5 hours. The reaction solution was cooled to room temperature, 15 ml of diethyl ether and 5 ml of 2N hydrochloric acid were added, and the mixture was stirred for 20 minutes and then separated. After the diethyl ether layer was extracted three times with 10 ml of a 5% aqueous sodium hydroxide solution, the aqueous layer was adjusted to pH 2 with 2N hydrochloric acid, and extracted twice with 20 ml of diethyl ether. The obtained diethyl ether layer was washed with saturated saline, dried over anhydrous magnesium sulfate, filtered and concentrated to obtain 0.23 g of the desired compound (2-1) (yield: 76%).
The isomer generation ratio of the obtained compound (2-1) is as follows:
(2α-1): (2β-1) = 6: 94.

【0080】実施例4Embodiment 4

【0081】[0081]

【化27】 Embedded image

【0082】窒素雰囲気下、酢酸パラジウム24.8mg
(1.1mmol)及びトリフェニルホスフィン57.6mg
(2.2mmol)をテトラヒドロフラン15mlに溶解した
溶液に、ギ酸2.02g(44.0mmol)及びトリエチ
ルアミン5.55g(55.0mmol)をテトラヒドロフ
ラン15mlに溶解した溶液を加え加熱還流した。この反
応液に参考例8で得られたアゼチジン−2−オン誘導体
(1b−2)5.68g(11.0mmol)をテトラヒド
ロフラン20mlに溶解した溶液を30分かけて滴下し、
さらに1.5時間撹拌を続けた。反応液を室温まで冷却
し、ジエチルエーテル80mlを加え、飽和食塩水30ml
で洗浄し、無水硫酸マグネシウムで脱水後、溶媒を減圧
留去して粗生成物4.41gを得た。次いで、−60℃
に冷却した液体アンモニア100mlに金属ナトリウム
1.29g(56.0 mmol)を加え、ナトリウムが溶解
して液が濃青色となったところで、上記で得た粗生成物
4.41gをジエチルエーテル20mlに溶解して溶液を
30分かけて滴下した。反応容器の冷却を止め、反応液
の撹拌を続けながら、一晩かけて室温に戻した。ジエチ
ルエーテル50ml及び水50mlを加え撹拌、次いで分液
を行い、得られた水層に、ジエチルエーテル層を5%水
酸化ナトリウム水溶液20mlで抽出したものを合わせた
後、希塩酸を用いてpH2とした。これを、ジエチルエー
テル100mlで抽出し、飽和食塩水30mlで洗浄した
後、無水硫酸マグネシウムで脱水、次いで濾過、濃縮を
行って、目的とする化合物(2−1)2.60g(収率
77%)を得た。なお、得られた化合物(2−1)の異
性体生成比は、(2α−1):(2β−1)=31:6
9であった。
Under a nitrogen atmosphere, 24.8 mg of palladium acetate
(1.1 mmol) and 57.6 mg of triphenylphosphine
(2.2 mmol) in a solution of 15 ml of tetrahydrofuran was added a solution of 2.02 g (44.0 mmol) of formic acid and 5.55 g (55.0 mmol) of triethylamine in 15 ml of tetrahydrofuran, and the mixture was heated under reflux. A solution of 5.68 g (11.0 mmol) of the azetidin-2-one derivative (1b-2) obtained in Reference Example 8 in 20 ml of tetrahydrofuran was added dropwise to the reaction solution over 30 minutes.
Stirring was continued for another 1.5 hours. The reaction solution was cooled to room temperature, 80 ml of diethyl ether was added, and 30 ml of saturated saline was added.
After dehydration with anhydrous magnesium sulfate, the solvent was distilled off under reduced pressure to obtain 4.41 g of a crude product. Then, -60 ° C
1.29 g (56.0 mmol) of metallic sodium was added to 100 ml of cooled liquid ammonia, and when the sodium dissolved and the solution turned dark blue, 4.41 g of the crude product obtained above was added to 20 ml of diethyl ether. Upon dissolution, the solution was added dropwise over 30 minutes. The cooling of the reaction vessel was stopped, and the temperature of the reaction solution was returned to room temperature overnight while stirring was continued. 50 ml of diethyl ether and 50 ml of water were added, followed by stirring and liquid separation. The obtained aqueous layer was combined with a solution obtained by extracting the diethyl ether layer with 20 ml of a 5% aqueous sodium hydroxide solution, and then adjusted to pH 2 with dilute hydrochloric acid. . This was extracted with 100 ml of diethyl ether, washed with 30 ml of saturated saline, dehydrated with anhydrous magnesium sulfate, filtered and concentrated to obtain 2.60 g of the desired compound (2-1) (yield 77%). ) Got. The isomer generation ratio of the obtained compound (2-1) was (2α-1) :( 2β-1) = 31: 6.
Nine.

【0083】実施例5Embodiment 5

【0084】[0084]

【化28】 Embedded image

【0085】参考例9で得られたアゼチジン−2−オン
誘導体(1b−3)1.09g(2.0mmol)、酢
酸パラジウム9.0mg(0.04mmol)、トリフ
ェニルホスフィン21.0mg(0.08mmol)、
ギ酸0.37g(8.0mmol)及びトリエチルアミ
ン0.91g(9.0mmol)を用いて、前記参考例
に従って脱エステル、脱炭酸反応を行った後、液体アン
モニア30ml及び金属ナトリウム0.24g(10.
0mmol)を用いて脱ベンジル化反応を行い、目的と
する化合物(2−1)0.48g(収率80%)を得
た。なお、得られた化合物(2−1)の異性体生成比
は、(2α−1):(2β−1)=39:61であっ
た。
1.09 g (2.0 mmol) of the azetidin-2-one derivative (1b-3) obtained in Reference Example 9, 9.0 mg (0.04 mmol) of palladium acetate, and 21.0 mg (0.0 mg) of triphenylphosphine. 08 mmol),
After deesterification and decarboxylation were performed using 0.37 g (8.0 mmol) of formic acid and 0.91 g (9.0 mmol) of triethylamine according to the above reference example, 30 ml of liquid ammonia and 0.24 g of metal sodium (10.
0 mmol) to obtain 0.48 g of the desired compound (2-1) (yield: 80%). The isomer generation ratio of the obtained compound (2-1) was (2α-1) :( 2β-1) = 39: 61.

【0086】実施例6Embodiment 6

【0087】[0087]

【化29】 Embedded image

【0088】参考例3で得られたアゼチジン−2−オン
誘導体(1a−3)1.58g(3.0mmol)、トリエ
チルアミン0.72g(7.1mmol)及び5%パラジウ
ム炭素0.3gをメタノール30mlに懸濁し、常圧で水
素添加を行った。濾過によりパラジウム炭素を除去した
後、メタノールを減圧留去し、残留物に飽和炭酸水素ナ
トリウム水溶液10ml及び酢酸エチル10mlを加えて撹
拌、分液を行った。水層を1N塩酸で酸性とし、生成し
た白色固体を濾別し、水洗後、減圧乾燥を行って、ジカ
ルボン酸化合物(8a)0.54g(収率52%)を得
た。 融点:110-111℃ MS(m/e):244,200 IR(KBr)cm-1:1755,17201 H-NMR δ(CD3OD):0.02(s,3H),0.04(s,3H),0.86(s,9H),
1.13(d,J=6.4Hz,3H),1.33(s,3H),3.01(dd,J=2.1,2.7Hz,
1H),4.19(d,J=2.1Hz,1H),4.20(m,1H)
1.58 g (3.0 mmol) of the azetidin-2-one derivative (1a-3) obtained in Reference Example 3, 0.72 g (7.1 mmol) of triethylamine and 0.3 g of 5% palladium carbon were added to 30 ml of methanol. And hydrogenated at normal pressure. After removing palladium carbon by filtration, methanol was distilled off under reduced pressure, and 10 ml of a saturated aqueous solution of sodium hydrogen carbonate and 10 ml of ethyl acetate were added to the residue, followed by stirring and liquid separation. The aqueous layer was acidified with 1N hydrochloric acid, the generated white solid was filtered off, washed with water, and dried under reduced pressure to obtain 0.54 g (52% yield) of a dicarboxylic acid compound (8a). Melting point: 110-111 ° C MS (m / e): 244,200 IR (KBr) cm -1 : 1755,1720 1 H-NMR δ (CD 3 OD): 0.02 (s, 3H), 0.04 (s, 3H), 0.86 (s, 9H),
1.13 (d, J = 6.4Hz, 3H), 1.33 (s, 3H), 3.01 (dd, J = 2.1,2.7Hz,
1H), 4.19 (d, J = 2.1Hz, 1H), 4.20 (m, 1H)

【0089】実施例7Embodiment 7

【0090】[0090]

【化30】 Embedded image

【0091】参考例2で得られたアゼチジン−2−オン
誘導体(1a−2)1.08g(2.7mmol)をエタノ
ール15ml及び水5mlに溶解し、これに、水酸化カリウ
ム0.99g(17.6mmol)を水3mlに溶解した溶液
を加えて、50℃に加熱し5時間撹拌を続けた。反応液
を室温まで冷却した後、水30mlに注ぎ、2N塩酸で酸
性とし、生成した白色固体を濾別し、水洗した後、減圧
乾燥を行って、ジカルボン酸化合物(8a)0.63g
(収率68%)を得た。
1.08 g (2.7 mmol) of the azetidin-2-one derivative (1a-2) obtained in Reference Example 2 was dissolved in 15 ml of ethanol and 5 ml of water, and 0.99 g (17%) of potassium hydroxide was added thereto. (3.6 mmol) in 3 ml of water was added, and the mixture was heated to 50 ° C. and stirred for 5 hours. After the reaction solution was cooled to room temperature, it was poured into 30 ml of water, acidified with 2N hydrochloric acid, the resulting white solid was separated by filtration, washed with water, and dried under reduced pressure to obtain 0.63 g of the dicarboxylic acid compound (8a).
(68% yield).

【0092】実施例8Embodiment 8

【0093】[0093]

【化31】 Embedded image

【0094】参考例4で得たアゼチジン−2−オン誘導
体(1a−4)及び(1a−5)の異性体混合物0.4
0g(0.93mmol)をエタノール2mlに溶解し、これ
に、水酸化カリウム0.34g(6.1mmol)を水3ml
に溶解した溶液を加えて、50℃で2日間攪拌を続け
た。反応液を減圧濃縮した後、1N塩酸を加えてpH2と
してからさらに減圧濃縮を行った。得られた固体にジエ
チルエーテル10mlを加え、良く攪拌した後、濾過、濃
縮を行ってジカルボン酸化合物(8a)0.21g(収
率66%)を得た。 実施例9
An isomer mixture 0.4 of the azetidin-2-one derivative (1a-4) and (1a-5) obtained in Reference Example 4.
0 g (0.93 mmol) was dissolved in 2 ml of ethanol, and 0.34 g (6.1 mmol) of potassium hydroxide was added to 3 ml of water.
Was added and stirring was continued at 50 ° C. for 2 days. After the reaction solution was concentrated under reduced pressure, 1N hydrochloric acid was added to adjust the pH to 2, followed by further concentration under reduced pressure. 10 ml of diethyl ether was added to the obtained solid, and the mixture was thoroughly stirred, filtered and concentrated to obtain 0.21 g (yield: 66%) of a dicarboxylic acid compound (8a). Example 9

【0095】[0095]

【化32】 Embedded image

【0096】参考例5で得たアゼチジン−2−オン誘導
体(1a−6)0.62g(1.0mmol)をエタノール
10ml及び水3mlに溶解し、これに、水酸化カリウム
0.38g(6.8mmol)を水3mlに溶解した溶液を加
えて、50℃で25時間攪拌を続けた。反応液を室温ま
で冷却した後、水30mlに注ぎ、ジエチルエーテル10
mlで2回抽出を行った。得られた水層を2N塩酸で酸性
とし、酢酸エチル15mlで2回抽出を行い、次いで、抽
出液を無水硫酸マグネシウムで脱水した後、濾過、減圧
乾燥を行って、ジカルボン酸化合物(8a)0.18g
(収率52%)を得た。 実施例10
0.62 g (1.0 mmol) of the azetidin-2-one derivative (1a-6) obtained in Reference Example 5 was dissolved in 10 ml of ethanol and 3 ml of water, and 0.38 g of potassium hydroxide (6. 8 mmol) in 3 ml of water was added and stirring was continued at 50 ° C. for 25 hours. After the reaction solution was cooled to room temperature, it was poured into 30 ml of water, and diethyl ether 10
Extraction was performed twice with ml. The resulting aqueous layer was acidified with 2N hydrochloric acid, extracted twice with 15 ml of ethyl acetate, and then the extract was dehydrated with anhydrous magnesium sulfate, filtered and dried under reduced pressure to obtain a dicarboxylic acid compound (8a). .18g
(52% yield). Example 10

【0097】[0097]

【化33】 Embedded image

【0098】参考例10で得られたアゼチジン−2−オ
ン誘導体(1b−4)2.40g(4.9mmol)にエタ
ノール5ml及び水10mlを加え、撹拌しながら、水酸化
カリウム1.10g(19.6mmol)を水5mlに溶解し
た溶液を加え、室温で一晩撹拌した。この反応液を水5
0mlに注ぎ、1N塩酸を加えてpH7とし、次いでジエチ
ルエーテル50mlを用いて抽出を行った。さらに、pH1
となるまで1N塩酸を加えた後、ジエチルエーテル50
mlを加え抽出を行い、得られたジエチルエーテル層を飽
和食塩水15mlで洗浄した後、無水硫酸マグネシウムで
脱水、次いで濾過、濃縮を行って、ジカルボン酸化合物
(8b)1.50g(収率69%)を得た。 融点:128-129℃ MS(m/e):334,290 IR(KBr)cm-1:1750,17301 H-NMR δ(CD3OD):0.01(s,3H),0.07(s,3H),0.86(s,9H),
1.16(d,J=6.4Hz,3H),1.21(s,3H),3.04(m,1H),4.21(m,1
H),4.30(d,J=15.2Hz,1H),4.45(d,J=2.1Hz,1H),4.46(d,J
=15.2Hz,1H),7.30(m,5H)
To 2.40 g (4.9 mmol) of the azetidin-2-one derivative (1b-4) obtained in Reference Example 10 were added 5 ml of ethanol and 10 ml of water, and 1.10 g of potassium hydroxide (19 (6 mmol) in 5 ml of water was added and stirred at room temperature overnight. This reaction solution is added to water 5
The mixture was poured into 0 ml, adjusted to pH 7 by adding 1N hydrochloric acid, and then extracted with 50 ml of diethyl ether. In addition, pH 1
After adding 1N hydrochloric acid until the mixture becomes
The resulting diethyl ether layer was washed with 15 ml of saturated saline, dried over anhydrous magnesium sulfate, filtered and concentrated to obtain 1.50 g of the dicarboxylic acid compound (8b) (yield: 69). %). Melting point: 128-129 ° C MS (m / e): 334,290 IR (KBr) cm -1 : 1750, 1730 1 H-NMR δ (CD 3 OD): 0.01 (s, 3H), 0.07 (s, 3H), 0.86 (s, 9H),
1.16 (d, J = 6.4Hz, 3H), 1.21 (s, 3H), 3.04 (m, 1H), 4.21 (m, 1
H), 4.30 (d, J = 15.2Hz, 1H), 4.45 (d, J = 2.1Hz, 1H), 4.46 (d, J
= 15.2Hz, 1H), 7.30 (m, 5H)

【0099】実施例11Embodiment 11

【0100】[0100]

【化34】 Embedded image

【0101】実施例6〜9で得られたジカルボン酸化合
物(8a)1.38g(4.0mmol)をジエチレングリ
コールジメチルエーテル15mlに溶解し、120℃で3
時間加熱した。反応液を室温まで冷却した後、ジエチル
エーテル20ml及び5%水酸化ナトリウム水溶液15ml
を用いて抽出を行い、水層をさらにジエチルエーテル1
0mlで洗浄した後、2N塩酸でpH2とし、ジエチルエー
テル30mlを用いて抽出を行った。得られたジエチルエ
ーテル層は、飽和食塩水10mlで洗浄した後、無水硫酸
マグネシウムで脱水、次いで濾過、濃縮を行って、目的
とする化合物(2−1)0.97g(収率80%)を得
た。なお、得られた化合物(2−1)の異性体生成比
は、(2α−1):(2β−1)=90:10であっ
た。
1.38 g (4.0 mmol) of the dicarboxylic acid compound (8a) obtained in Examples 6 to 9 were dissolved in 15 ml of diethylene glycol dimethyl ether.
Heated for hours. After the reaction solution was cooled to room temperature, 20 ml of diethyl ether and 15 ml of a 5% aqueous sodium hydroxide solution were used.
The aqueous layer was extracted with
After washing with 0 ml, the mixture was adjusted to pH 2 with 2N hydrochloric acid and extracted with 30 ml of diethyl ether. The obtained diethyl ether layer was washed with 10 ml of saturated saline, dehydrated with anhydrous magnesium sulfate, filtered and concentrated to obtain 0.97 g (yield 80%) of the desired compound (2-1). Obtained. The isomer generation ratio of the obtained compound (2-1) was (2α-1) :( 2β-1) = 90: 10.

【0102】実施例12Embodiment 12

【0103】[0103]

【化35】 Embedded image

【0104】実施例10で得られたジカルボン酸化合物
(8b)0.87g(2.0mmol)を前記実施例11に
従って加熱脱炭酸反応を行った後、前記実施例4に従っ
て液体アンモニア及び金属ナトリウムを用いて脱ベンジ
ル化反応を行い、目的とする化合物(2−1)0.42
g(収率70%)を得た。なお、得られた化合物(2−
1)の異性体生成比は、(2α−1):(2β−1)=
28:72であった。
After subjecting 0.87 g (2.0 mmol) of the dicarboxylic acid compound (8b) obtained in Example 10 to a heat decarboxylation reaction according to Example 11, liquid ammonia and metallic sodium were added according to Example 4. Compound (2-1) 0.42
g (70% yield). In addition, the obtained compound (2-
The isomer formation ratio of 1) is (2α-1) :( 2β-1) =
28:72.

【0105】[0105]

【発明の効果】本発明によれば、1β−アルキルカルバ
ペネム系抗菌剤の合成中間体として有用な4−(1−カ
ルボキシアルキル)アゼチジン−2−オン誘導体を効率
よく製造することができる。
According to the present invention, a 4- (1-carboxyalkyl) azetidin-2-one derivative useful as a synthetic intermediate for a 1β-alkylcarbapenem-based antibacterial agent can be efficiently produced.

フロントページの続き (72)発明者 小林 東洋彦 東京都大田区蒲田5丁目36番31号 高砂 香料工業株式会社 総合研究所内 (58)調査した分野(Int.Cl.6,DB名) C07D 205/08 CA(STN) REGISTRY(STN)Continuation of the front page (72) Inventor Hirohiko Kobayashi 5-36-31 Kamata, Ota-ku, Tokyo Takasago Incense Research Institute, Inc. (58) Field surveyed (Int.Cl. 6 , DB name) C07D 205 / 08 CA (STN) REGISTRY (STN)

Claims (3)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 一般式(1) 【化1】 (式中、R1及びR2は同一又は異なって、それぞれアル
キル基、アルケニル基又はアラルキル基を示し、R3
低級アルキル基を示し、R4は水素原子又は水酸基の保
護基を示し、R5は水素原子又はアミノ基の保護基を示
す)で表される4−(1,1−ジアルコキシカルボニル
アルキル)アゼチジン−2−オン誘導体を脱エステル及
び脱炭酸せしめ、アミノ基の保護基が存在する場合には
脱保護せしめることを特徴とする一般式(2) 【化2】 (式中、R3及びR4は前記と同じ意味を示す)で表され
る4−(1−カルボキシアルキル)アゼチジン−2−オ
ン誘導体の製造法。
1. A compound of the general formula (1) (Wherein R 1 and R 2 are the same or different and each represent an alkyl group, an alkenyl group or an aralkyl group, R 3 represents a lower alkyl group, R 4 represents a hydrogen atom or a protecting group for a hydroxyl group, 5 is a hydrogen atom or an amino-protecting group), and the 4- (1,1-dialkoxycarbonylalkyl) azetidin-2-one derivative is de-esterified and decarboxylated, and an amino-protecting group is present. In general, the compound is deprotected in the case of (Wherein R 3 and R 4 have the same meanings as described above), and a method for producing a 4- (1-carboxyalkyl) azetidin-2-one derivative represented by the formula:
【請求項2】 一般式(1)において、R5がアミノ基
の保護基を示し、脱エステル及び脱炭酸反応後、当該ア
ミノ基の保護基を脱離せしめることを特徴とする請求項
1記載の製造法。
2. The compound according to claim 1, wherein in the general formula (1), R 5 represents a protecting group for an amino group, and after the esterification and decarboxylation reaction, the protecting group for the amino group is eliminated. Manufacturing method.
【請求項3】 一般式(1)において、R1及びR2が2
−アルケニル基であり、脱エステル及び脱炭酸反応が一
般式(1)で表されるアゼチジン−2−オン誘導体に、
パラジウム化合物の存在下、ギ酸又はギ酸のアミン塩を
反応させることにより行われるものである請求項1記載
の製造法。
3. In the general formula (1), R 1 and R 2 are 2
-An alkenyl group, wherein the deesterification and decarboxylation reactions are performed on an azetidin-2-one derivative represented by the general formula (1):
2. The process according to claim 1, wherein the reaction is carried out by reacting formic acid or an amine salt of formic acid in the presence of a palladium compound.
JP3338673A 1991-12-09 1991-12-20 Method for producing 4- (1-carboxyalkyl) azetidin-2-one derivative Expired - Lifetime JP2958835B2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP3338673A JP2958835B2 (en) 1991-12-20 1991-12-20 Method for producing 4- (1-carboxyalkyl) azetidin-2-one derivative
DE69231883T DE69231883T2 (en) 1991-12-09 1992-11-30 4- (1,1-dialkoxycarbonyl-alkyl) azetidin-2-one derivatives for the preparation of 4- (1-carboxy-alkyl) azetidin-2-one derivatives
EP92310901A EP0546742B1 (en) 1991-12-09 1992-11-30 4-(1,1-Dialkoxycarbonyl-alkyl)azetidin-2-one derivatives and synthesis of 4-(1-carboxy-alkyl)azetidin-2-one derivatives therefrom
US07/987,779 US5371214A (en) 1991-12-09 1992-12-09 4-(1,1-dialkoxycarbonylalkyl)azetidin-2-one derivative and process for producing 4-(1-carboxyalkyl)azetidin-2-one derivative using the same
US08/277,319 US5574152A (en) 1991-12-09 1994-07-25 4-(1,1-dialkoxycarbonylalkyl) azetidin-2-one derivative and process for producing 4-(1-carboxyalkyl) azetidin-2-one derivative using the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3338673A JP2958835B2 (en) 1991-12-20 1991-12-20 Method for producing 4- (1-carboxyalkyl) azetidin-2-one derivative

Publications (2)

Publication Number Publication Date
JPH05170733A JPH05170733A (en) 1993-07-09
JP2958835B2 true JP2958835B2 (en) 1999-10-06

Family

ID=18320385

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3338673A Expired - Lifetime JP2958835B2 (en) 1991-12-09 1991-12-20 Method for producing 4- (1-carboxyalkyl) azetidin-2-one derivative

Country Status (1)

Country Link
JP (1) JP2958835B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200806624A (en) 2006-06-16 2008-02-01 Kaneka Corp An improved method for crystallization of an azetidinone corboxylic acid

Also Published As

Publication number Publication date
JPH05170733A (en) 1993-07-09

Similar Documents

Publication Publication Date Title
US6340767B1 (en) Processes for the preparation of 5-hydroxy-3-oxopentanoic acid derivatives
JPH06172256A (en) Production of 3-hydroxybutyric acid derivative
JP2958834B2 (en) Azetidin-2-one derivatives
EP0546742B1 (en) 4-(1,1-Dialkoxycarbonyl-alkyl)azetidin-2-one derivatives and synthesis of 4-(1-carboxy-alkyl)azetidin-2-one derivatives therefrom
JP4303792B2 (en) Method for producing quinolone derivative
JPH0987258A (en) Oxazolines, their production and production of asymmetric cyclopropanecarboxylic acids
JP2958835B2 (en) Method for producing 4- (1-carboxyalkyl) azetidin-2-one derivative
EP1035127B1 (en) Process for the preparation of N-[5-(Diphenylphosphinoylmethyl)-4-(4-fluorphenyl)-6-isopropylpyrimidin-2-yl]-N-methylmethansulfonamide
JP2769058B2 (en) Preparation of cyclopropane derivatives
US4754029A (en) 3-oxo-2-azabicyclohexane derivatives
JPH08283203A (en) Production of asymmetric cyclopropanecarboxylic acid compound
JP2776995B2 (en) Process for producing (R)-(+)-dihydro-α-ionone and novel intermediate thereof
JPS6332351B2 (en)
JP2781216B2 (en) Method for producing 4-acyloxyazetidinone-2-one
JP4060718B2 (en) New production method of enol ether
JPH0147467B2 (en)
JP4085601B2 (en) Process for producing optically active pyridyl alcohols
JPH08231469A (en) Cyclopentanecarboxylic acid derivative and its production
JPH051002A (en) Production of alpha-amino acid
JPH0717945A (en) Production of substituted cyclic compound
JPS643187B2 (en)
JPS643188B2 (en)
JPH1045721A (en) Production of 1-substituted-4,5-diphenyl-2-imidazolidinone and intermediate for the same
KR20020073751A (en) Beta-substituted-gamma-butyrolactones and preparation process thereof
JPH02223539A (en) Production of substituted cyclopropane-1,1-dicarboxylic acid derivative and intermediate thereof